tert-Butyl 3-bromo-5-chloro-1H-indole-1-carboxylate

Catalog No. :
ACXGOP620
CAS No. :
1303543-80-7
Molecular Formula :
C13H13BrClNO2
Molecular Weight :
330.61

IUPAC Name:tert-butyl 3-bromo-5-chloro-1H-indole-1-carboxylate

tert-Butyl 3-bromo-5-chloro-1H-indole-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$203.00Login to see priceInquiryInquiry
250mg95%$374.00Login to see priceInquiryInquiry
1g95%$935.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 3-bromo-5-chloro-1H-indole-1-carboxylate
IUPAC Nametert-butyl 3-bromo-5-chloro-1H-indole-1-carboxylate
MDL No.MFCD14635677
Molecular FormulaC13H13BrClNO2
Molecular Weight330.61
SMILESO=C(OC(C)(C)C)N1C=C(C2=C1C=CC(Cl)=C2)Br
InChI KeyUOIWZZMFVYUBCV-UHFFFAOYSA-N
Synonymtert-butyl 3-bromo-5-chloro-1H-indole-1-carboxylate;1H-Indole-1-carboxylic acid, 3-bromo-5-chloro-, 1,1-dimethylethyl ester;1-Boc-3-bromo-5-chloroindole
CAS No.1303543-80-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACXGOP620 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACLJNK751 route compound structure diagram
    ACLJNK75185092-82-6 In Stock
  4. Then
  5. ACXGOP620 route product structure diagram
    ACXGOP6201303543-80-7
Inquiry

2. ACXGOP620 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACLJNK751 route compound structure diagram
    ACLJNK75185092-82-6 In Stock
  4. Then
  5. ACXGOP620 route product structure diagram
    ACXGOP6201303543-80-7
Inquiry

Comments (0)